| Factors associated with HPV vaccine uptake in teenage girls: a systematic review SJM Kessels, HS Marshall, M Watson, AJ Braunack-Mayer, R Reuzel, ... Vaccine 30 (24), 3546-3556, 2012 | 535 | 2012 |
| Respiratory syncytial virus vaccination during pregnancy and effects in infants SA Madhi, FP Polack, PA Piedra, FM Munoz, AA Trenholme, EAF Simões, ... New England Journal of Medicine 383 (5), 426-439, 2020 | 318 | 2020 |
| Vaccine hesitancy, refusal and access barriers: The need for clarity in terminology H Bedford, K Attwell, M Danchin, H Marshall, P Corben, J Leask Vaccine 36 (44), 6556-6558, 2018 | 311 | 2018 |
| The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent? C Patel, JML Brotherton, A Pillsbury, S Jayasinghe, B Donovan, ... Eurosurveillance 23 (41), 1700737, 2018 | 310 | 2018 |
| Confirmation of the association between high levels of immunoglobulin E food sensitization and eczema in infancy: An international study. SMTESGMH Hill D, Hosking C, de Benedictis F, Oranje A, Diepgen T, Bauchau V ... Clinical and Experimental Allergy 38 (1), 161-168, 2008 | 285 | 2008 |
| Understanding the school community’s response to school closures during the H1N1 2009 influenza pandemic A Braunack-Mayer, R Tooher, JE Collins, JM Street, H Marshall BMC public health 13, 1-15, 2013 | 275 | 2013 |
| Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in infants and children: a randomized trial T Nolan, J McVernon, M Skeljo, P Richmond, U Wadia, S Lambert, ... Jama 303 (1), 37-46, 2010 | 233 | 2010 |
| Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia C Lam, S Octavia, L Ricafort, V Sintchenko, GL Gilbert, N Wood, ... Emerging infectious diseases 20 (4), 626, 2014 | 219 | 2014 |
| The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination SR Parikh, H Campbell, JA Bettinger, LH Harrison, HS Marshall, ... Journal of Infection 81 (4), 483-498, 2020 | 196 | 2020 |
| Meningococcal B vaccine and meningococcal carriage in adolescents in Australia HS Marshall, M McMillan, AP Koehler, A Lawrence, TR Sullivan, ... New England Journal of Medicine 382 (4), 318-327, 2020 | 179 | 2020 |
| Influenza vaccination during pregnancy: a systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes M McMillan, K Porritt, D Kralik, L Costi, H Marshall Vaccine 33 (18), 2108-2117, 2015 | 178 | 2015 |
| Vaccine decision-making begins in pregnancy: correlation between vaccine concerns, intentions and maternal vaccination with subsequent childhood vaccine uptake MH Danchin, J Costa-Pinto, K Attwell, H Willaby, K Wiley, M Hoq, J Leask, ... Vaccine 36 (44), 6473-6479, 2018 | 176 | 2018 |
| Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo … PC Richmond, HS Marshall, MD Nissen, Q Jiang, KU Jansen, ... The Lancet infectious diseases 12 (8), 597-607, 2012 | 175 | 2012 |
| Early-life antibiotic-driven dysbiosis leads to dysregulated vaccine immune responses in mice MA Lynn, DJ Tumes, JM Choo, A Sribnaia, SJ Blake, LEX Leong, ... Cell host & microbe 23 (5), 653-660. e5, 2018 | 169 | 2018 |
| Maternal influenza and birth outcomes: systematic review of comparative studies DB Fell, DA Savitz, MS Kramer, BD Gessner, MA Katz, M Knight, ... BJOG: An International Journal of Obstetrics & Gynaecology 124 (1), 48-59, 2017 | 162 | 2017 |
| Case fatality rates of invasive meningococcal disease by serogroup and age: a systematic review and meta-analysis B Wang, R Santoreneos, L Giles, HHA Afzali, H Marshall Vaccine 37 (21), 2768-2782, 2019 | 155 | 2019 |
| Congenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data M DeSilva, FM Munoz, M Mcmillan, AT Kawai, H Marshall, KK Macartney, ... Vaccine 34 (49), 6015, 2016 | 153 | 2016 |
| Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age N Wood, P McIntyre, H Marshall, D Roberton The Pediatric infectious disease journal 29 (3), 209-215, 2010 | 150 | 2010 |
| A cross‐sectional survey to assess community attitudes to introduction of Human Papillomavirus vaccine H Marshall, P Ryan, D Roberton, P Baghurst Australian and New Zealand journal of public health 31 (3), 235-242, 2007 | 141 | 2007 |
| A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults HS Marshall, PC Richmond, MD Nissen, A Wouters, J Baber, Q Jiang, ... Vaccine 31 (12), 1569-1575, 2013 | 116 | 2013 |
